The unprecedented challenges of Coronavirus Disease 2019 (COVID-19) have pushed the
limits of medicine and health care over the tipping point of what we thought imaginable,
forcing solutions to problems that previously mired rapid progress. Nowhere has this
been more apparent than in technology, where both its accelerated advances and shortcomings
have come into sharp contrast during the current pandemic. Whereas classic infection-control
and public health measures were used during the severe acute respiratory syndrome
(SARS) epidemic in 2003, COVID-19 provides the opportunity to explore the potential
of new digital technologies, including big data analytics, artificial intelligence,
blockchain technology, and the Internet of Things.
1
Among the many available digital technologies, O’Reilly-Shah et al
2
in this issue of Anesthesia & Analgesia address not only the potential benefits but
also the barriers to adopting health informatics for patient care during the COVID-19
pandemic.
2
They review concerns around current gaps in technology, including data privacy and
ethics, we well as data silos and sharing. They highlight the lack of data infrastructure
and interoperability as barriers to patient care and public health efforts during
the pandemic. A recent study similarly observed that barriers to public health agencies
receiving hospital-level data on COVID-19 patients included the inability to electronically
receive data, interface-related issues, difficulty extracting data from the electronic
health record (EHR), and different vocabulary standards.
3
O’Reilly Shah et al
2
also highlight concrete examples of the pandemic pushing the creative edges of technology.
2
Like other authors,
4
they note the proliferation of clinical decision support tools such as best practice
alerts, order sets, and dashboards designed to track real-time COVID-19 updates in
a hospital.
While O’Reilly-Shah et al
2
review the advantages and gaps currently existing specifically in clinical informatics,
2
technology―in all of its forms―is rapidly evolving to address the pandemic. The apparent
transition to the postinitial surge phase of the COVID-19 pandemic serves as an inflection
point to reflect on the potential technological contributions of anesthesiology and
anesthesiologists. Considering the expansive array of digital technologies available
to contemporary health care, we take the liberty in this current editorial to discuss
the anesthesiologist’s optimal role in this broader arena.
Indeed, equally relevant to any discussion on technological innovation are the creative
nondigital solutions that have been implemented during the initial COVID-19 surge.
Many of these were developed by necessity, such as alternative personal protective
equipment (PPE) options and reprocessing and sterilization techniques for N95 respirator
masks. Critical shortages of PPE-motivated amateurs and expert manufacturers to utilize
3-dimensional (3D) printing to create medical supplies like face shields, face masks,
and nasal swabs. Novel medical technologies like intubation boxes to minimize aerosolization,
splitting ventilators, and new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
testing and treatment options are continually being developed.
The specialty of anesthesiology has a strong track record of innovations in medical
device technology―witnessed again with COVID-19. We posit, however, that the current
pandemic offers a unique opportunity to contribute to emerging digital technologies
that have not been conventionally considered part of the purview of anesthesiology.
This includes expanding our roles in telehealth platforms and remote monitoring and
surveillance in the inpatient and outpatient settings, thereby adding significant
value to the continuum of care through perioperative medicine. As we expand these
technologies, it will be incumbent upon us to apply equally innovative metrics to
measure the clinical and quality outcomes of these interventions in the perioperative
setting.
TELEHEALTH VISITS AND REMOTE PATIENT MONITORING
One of the most striking transformations during the current pandemic has been the
rapid adoption of telehealth and telemedicine. Before the emergence of COVID-19, despite
impressive advances in video and mobile technology, telehealth progress was stymied
by highly restrictive stipulations by the US Centers for Medicare & Medicaid Services
(CMS), state boundaries, and poor reimbursement. The pandemic has spurred federal
and state regulators to level the playing field by reducing barriers to telehealth
adoption, including reimbursement parity laws and relaxing state geographical restrictions.
The expansions also included several CMS emergency initiatives that expanded Medicare
and Medicaid coverage, increasing the modalities and sites of coverage, such as personal
residences, federally qualified health centers, and rural clinics.
5
Congress passed relief bills allowing the US Department of Health and Human Services
to approve telehealth grants, and the Federal Communications Commission started a
COVID-19 Telehealth program. States followed suit with emergency directives to increase
telehealth access and coverage.
State-level, COVID-19–related shelter-in-place mandates prompted rapid implementation
efforts highly relevant for the vast majority of specialties, including anesthesiology.
6–8
As early adopters of telemedicine in the perioperative setting, our respective health
systems realized a marked increase in opportunities to expand virtual preoperative
consultation for patients. Facilitating the expansion of telehealth platforms simultaneously
assisted staff and patients to adhere to statewide shelter-in-place mandates, reduce
risk of exposure, and preserve PPE during the initial surges of the pandemic.
9
The preoperative anesthesia clinics at our health systems rapidly adapted our existing
telehealth workflow, allowing us to continue to risk stratify, optimize, and prioritize
surgical cases when elective procedures were postponed. Anecdotally, one of our institutions
implemented an increase from 30% audiovideo visits to nearly 100% within one business
day. Our experiential learning from this radical transformation reflects what others
have reported about their telehealth experiences during the pandemic.
6
The challenges, opportunities, and solutions experienced by our preoperative medicine
and pain medicine clinics during this transition are listed in Table 1.
Table 1.
Lessons Learned From Rapid Telehealth Implementation for Anesthesiology-Led Clinics
Challenge
Opportunity and/or Resolution
Reimbursement for virtual visits
Temporary waiving of requirements with “Act”
Patient’s lack of adequate Internet access or usable electronic devices
Patient education and intake materials sent ahead of appointmentUse of additional
modalities approved by the “Act” (eg, Apple FaceTime, Facebook Messenger Video Chat,
Google Hangouts Video, or Skype)
Enrolling patients into electronic health portal and access to virtual visits
Patient education team increased outreach and enrollment efforts
Access to interpreter services
Partnered with hospital interpreter services for virtual visits
Training and resources for virtual visits
Remote access training and home laptops coordinated for clinic staff
Shelter-in-place mandate and personal protective equipment conservation
Preoperative and pain virtual visits offered to all patients
Preoperative diagnostic testing(eg, laboratory testing, electrocardiogram, and/or
imaging)
Obtained prior medical records to limit new testingTesting deferred to morning of
surgery when possibleCoordinated with primary care physician if needed before surgery
Inability to obtain reliable remote physical examination and vital signs
Airway examination conducted through virtual visitVital signs recorded from patient’s
home devices if possibleSeveral in-person visits to auscultate new cardiac murmursConsideration
of long-term facilitated telemedicine options
Patient experience
Initiated ongoing patient experience survey with preliminary positive results
Staff experience
Staff expressed ease of learning telehealth platform and satisfaction at work-from-home
safety measures
Abbreviation: “Act,” Coronavirus Preparedness and Response Supplemental Appropriations
Act.
The initial COVID-19 pandemic surge and shelter-in-place mandates reduced our capability
to perform a conventional physical examination of our patients, leading to the creative
application of remote patient monitoring (RPM) and surveillance technologies. In the
ambulatory setting, we shifted our reliance on patient-entered outcome data to remote
monitoring in several scenarios, including continuous glucose monitors for glycemic
control of insulinoma patients; Bluetooth weight scales for patients with congestive
heart failure; consumer actigraphs to evaluate activity levels; and Bluetooth-enabled
blood pressure cuffs to titrate alpha-blockade of pheochromocytoma patients.
Within the hospital, remote surveillance offers unique abilities to safety monitor
patients in non–intensive care unit (ICU) settings while conserving scarce medical
equipment and PPE. Safavi et al
10
describe the prerequisites and limitations for proper remote surveillance so clinicians
can identify patients at risk for physiological deterioration.
10
Their technological blueprints illustrate the importance of electronic medical records
(EMR)–based database structures and data lakes and the design challenges to assure
reliable information access and interpretation.
Knowledge gained from the inpatient setting has direct application for monitoring
infectious disease outside the hospital using patient self-entered clinical data.
For example, institutions across the country have implemented EHR-embedded tools to
remotely monitor asymptomatic, COVID-positive patients at home
11
; and to detect physiological deterioration with remote monitoring (pulse oximetry
and temperature), asynchronous questionnaires, and video visits to advise a return
to the hospital or clinic only if a patient becomes febrile or dyspneic or exhibits
oxygen desaturation.
12
This progress made in COVID-19 outpatient remote surveillance will advance postdischarge
follow-up in the perioperative setting. There is growing impetus for surgeon-anesthesiologist
to collaboratively participate in the “hospital-at-home” paradigm.
13,14
Improving effectiveness and efficiency through clinical pathways will also reduce
hospital-acquired infections and other complications, thereby reducing length-of-stay―all
of which are paramount as we define the “new normal” in perioperative care. Therefore,
current successful experience with remotely triaging and managing asymptomatic COVID-19
patients can pave the way to widespread future RPM implementation in the postoperative
discharge setting. Anesthesiologists are well-trained to triage and to manage postsurgical
patients using RPM technologies, and can thus potentially serve as reliable touchpoints
for the 7- or 14-day transition of care visit in the outpatient setting.
Similar to EHR platforms, however, telehealth and RPM technologies have unresolved
limitations. Issues of data privacy and sharing, along with the shortcomings of digital
infrastructures exist in these areas. We cannot ignore the digital divide and inequity
of adoption that can occur along racial, ethnic, and socioeconomic lines, including
limited access in underserved areas or among vulnerable patient populations.
15
Public policy must support sustainable reimbursement models for virtual health visits.
Finally, robust outcomes research is necessary to assess the clinical effectiveness
of these new technologies for patient care. While COVID-19 certainly has convinced
some previous skeptics of the relevance and safety of telehealth, O’Reilly-Shah et
al
2
aptly remind us to identify and address its limitations.
IMPLICATIONS ON THE DELIVERY OF CARE: REDESIGNING QUALITY AND CLINICAL METRICS TO
REFLECT TECHNOLOGY PRE- AND POST-COVID
O’Reilly-Shah et al
2
reflect on the ethics and privacy challenges with data-sharing.
2
Demonstrating and measuring improvement are equally relevant to the successful implementation
and sustainability of any technological platform. Creating a robust and consistent
framework in these areas will ensure that the impact of technological advances on
the quality, safety, and access to care are validly measured.
Certain types of technology, specifically, telehealth and telemedicine, have an assessment
process recommended by national organizations, including the National Quality Forum
(NQF), which could be extrapolated to measure the impact of other emerging technologies
like predictive analytics and machine learning. The NQF has identified 3 factors most
relevant to the adoption of technology: measuring its effect on quality outcomes,
processes, and cost; selecting widely impactful quality measures; and using consistent
definitions.
16
The NQF also has defined essential categories for measuring telehealth as a means
of care delivery, including access to care, financial impact to patients and their
care providers, patient and clinician experience, and effectiveness of clinical and
operational systems. Among these, the NQF suggested 6 priority areas: travel, timeliness
of care, actionable information, impact of telehealth in providing evidence-based
practices, patient empowerment, and care coordination. These NQF recommendations can
serve as a guide in creating metrics for the impact of technology in anesthesiology
and perioperative medicine.
Using the quality domain as a framework to monitor the outcomes, access, and consistency
of innovative technologies also has implications for how these modalities can be included
in payment systems. For instance, the NQF has suggested incorporating telehealth and
telemedicine into the Merit-Based Incentive Payment System (MIPS) with respect to
providing expanded practice access and encouraging population health management. Each
of the 9 MIPS improvement activity (IA) subcategories can be used to measure the impact
of technology in anesthesiology and perioperative medicine (Table 2).
Table 2.
Technology Improvement Activities for Anesthesiology and Perioperative Medicine
IA Subcategory
Example
Expanded practice access
Expanded telehealth hours in preoperative anesthesia clinic
Population management
Use of QCDR to track population outcomes during pre- and postoperative consultation
Care coordination
Implementing care coordination and transitions of care planning in preoperative, postoperative,
and postdischarge settings
Beneficiary engagement
Use of electronic patient portals for preoperative optimization and patient education
Patient safety and practice assessment
Use of risk assessment tools (eg, NSQIP Surgical Risk Calculator)
Participation in APM
Hospital-at-home model
Achieving health equity
Measuring access to virtual visits in preoperative and postdischarge settings for
patients from different geographical locations
Emergency response and preparedness
COVID-19 preparation as crisis care situation and public health emergency
Integrated behavioral and mental health
Smoking cessation interventions in preoperative clinic
Abbreviations:APM,alternative payment model;
COVID-19,CoronavirusDisease2019; IA, improvement activity;
NSQIP,National Surgical Quality Improvement Program; QCDR, Qualified Clinical Data
Registry.
While the COVID-19 pandemic accelerated technological innovation and facilitated easing
of existing regulations for clinicians and federal technological oversight, it does
not absolve practitioners from thoughtful analysis of the impact of new technology
on care delivery. We advocate using consistent quality and clinical outcome measures
in evaluating any technological platform and suggest how these can be easily applied
to anesthesiology and perioperative medicine. Establishing a uniform framework will
ensure addressing the ethical and health equity implications of technology as we chart
a new course after the initial COVID-19 surge.
ADVANCING PERIOPERATIVE MEDICINE AND VALUE-BASED CARE THROUGH TECHNOLOGICAL INNOVATION
In the inevitable post-COVID pandemic era, what is the anesthesiologist’s role in
technology as our health care systems and other major stakeholders define the “new
normal?” Is this our opportunity to take a legitimate seat at the table of state and
national discussions on value-based care and population health management strategies
using our understanding of the continuum of care from the preoperative phase through
the postdischarge phase?
We will need to consider the optimal role of technology in addressing the currently
accrued, and likely future ebbing and flowing “care debt” of deferred surgical treatment
due to canceled elective procedures, as well as deferred medical conditions that worsen
and require emergency procedural intervention.
Others have also suggested this window as a launching point for discussion on value-based
care approaches in surgical and perioperative team-based settings.
13
Working collaboratively will incorporate all members of a multidisciplinary team,
including surgeons, anesthesiologists, nurses, physical therapists, and others, to
embrace care delivery models that promote high value and efficient clinical care pathways
and empower patients and caregivers through their coproduction and increased use of
patient-reported outcomes.
Future innovation of technological platforms will allow decentralized care delivery
through virtual pre- and postoperative appointments and the growth of home-based care
and rehabilitation. As anesthesiologists, we are uniquely positioned to add meaningful
value to this discussion. We are not only able to monitor and treat continuously changing
physiologic parameters but also to adapt to ever-evolving environments. These abilities
contribute new dimensions to future care delivery models. Leveraging our specialty’s
strengths in technology, hemodynamic monitoring, and predictive analytics provides
the platform to redesign and advance our profession and perioperative medicine after
the initial COVID-19 surge and beyond. The tipping point has arrived, technology will
certainly advance, and adoption is sure to generate discontent. It is our duty and
calling to embrace these frontiers and opportunities in the name of both invention
and progress.
DISCLOSURES
Name: Amy Lu, MD, MPH.
Contribution: This author helped draft the article and with the final approval of
the manuscript.
Conflicts of Interest: None.
Name: Maxime Cannesson, MD, PhD.
Contribution: This author helped draft the article and with the final approval of
the manuscript.
Conflicts of Interest: M.C. is a consultant for Edwards Lifesciences (Irvine, CA)
and Masimo Corp (Irvine, CA), and has funded research from Edwards Lifesciences and
Masimo Corp. He is also the founder of Sironis, and he owns patents and receives royalties
for closed-loop hemodynamic management technologies that have been licensed to Edwards
Lifesciences.
Name: Nirav Kamdar, MD, MPP, MBA.
Contribution: This author helped draft the article and with the final approval of
the manuscript.
Conflicts of Interest: N.K. is a scientific advisor to HAI Solutions LLC (Carlsbad,
CA), and Heartcloud Inc (Irvine, CA).
This manuscript was handled by: Thomas R. Vetter, MD, MPH.